FTO and metabolic dysfunction-associated steatotic liver disease: Further, expression of the m6A METTL3 writing complex, erasers (demethylases: FTO and ALKBH5), and m6A readers (RBPs) are altered in human NAFLD and in experimental models of liver disease and contribute to NAFLD, HCC, and CCA.